Treatment of cannabis use disorder: current science and future outlook. Pharmacotherapy. 2016;36(5):511-535. doi:10.1002/phar.1747PubMedGoogle ScholarCrossref 13. Ronsley C, Nolan S, Knight R, et al. Treatment of stimulant use disorder: a systematic review of reviews. ...
Potential models explaining SNV associations for neuropsychiatric disorders, substance use behaviors, and longevity endpoints eReferences Supplement 2. eTable 1. Phenotype descriptions and sources eTable 2. Instruments for substance use and use disorders eTable 3. Instruments for schizophrenia, bipolar ...
included metabolic and receptor genes. These findings provide insight into genetic risk loci for substance use disorders that could be leveraged as treatment targets. Access options Subscribe to this journal Receive 12 digital issues and online access to articles ...
Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence. Psychiatr Serv. 2012;63(7):679-685.PubMedGoogle ScholarCrossref 102. Pettinati HM, Weiss RD, Miller WR, Donovan D, Ernst DB, Rounsaville BJ. Medical Management Treatment ...
Treatment of opioid use disorder among commercially insured patients in the context of the COVID-19 pandemic. JAMA. 2020;324:2440–2. Article CAS Google Scholar Office of National Drug Control Policy. National Drug Control Strategy: National Treatment Plan for Substance Use Disorder 2020. ...
PubMedGoogle Scholar Medical Marijuana Laws and Cannabis Use JAMA Psychiatry Editorial June 1, 2017 See More About Substance Use and Addiction Medicine Adolescent Medicine Pediatrics Trending Medical Marijuana Legalization and Opioid and Pain Outcomes in Patients Receiving Cancer Treatment JAMA Oncology ...
Forest Plots of Treatment Effect Sizes of Contingency Management vs Controls: Therapy Attendance and Medication Adherence View LargeDownload aExperiment 1. bExperiment 2. Podcast (23:38) Contingency Management for Patients Receiving Medication for Opioid Use Disorder 1x 0:00 / 0:00 Subscribe to ...
Opioid agonist treatment was also found to be cost-saving as an intervention to reduce the risk of mortality after release from incarceration.78 Guidelines have been developed in the UK recommending and informing the use of OAT in carceral settings and after release79; international guidelines are ...
Moderate alcohol use and reduced mortality risk: systematic error in prospective studies. Addict Res Theory. 2006;14(2):101-132. doi:10.1080/16066350500497983 Google ScholarCrossref 3. Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic ...
Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database Syst Rev. 2020;3(3):CD012880. PubMedGoogle Scholar 15. National Committee for Quality Assurance. Initiation and engagement of alcohol and other drug abuse or dependence treatment (IET). Accessed ...